Futura Medical
On the cusp of MED3000 commercialisationFutura Medical
Interims highlight positive first signs in key marketsFutura Medical
FM71 achieves all primary and secondary endpointsFutura Medical
Major MED3000 deal for Europe with Cooper HealthFutura Medical
FY21 results reassure on cash runway and hint at EU dealFutura Medical
Menarini to commercialise MED3000 in South KoreaFutura Medical
Management update details degree of 2021 progressFutura Medical
A year of delivery, with key milestones achievedFutura Medical
Raising £12m through £10m placing and £2m retail offerFutura Medical
MED3000 receives CE Mark as a Class II(b) device